Targeted prostate cancer treatment cuts risk of side effects, study suggests

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

SUBSCRIBE TO RIVIERA READY

Travel, fashion, culture and Riviera-inspired living — delivered straight to your inbox.

By subscribing, you agree to receive Riviera Ready Magazine emails. You can unsubscribe at any time. Please read our Privacy Policy. This newsletter is intended for readers aged 16 or over.